Master of Science in Cancer Immunology and Biotechnology
University of Nottingham - University Park Campus
UK,England
0 Shortlist
12 Months
Duration
CAD 30,200/year
Tuition Fee
CAD 50
Application Fee
Apply Date
UK, England
Type: University
Location Type: Semi-Urban
Founded: 1948
Total Students: 48,000 +
Campus Detail
Main Campus Address
University Park, Nottingham NG7 2RD, United Kingdom
Master of Science in Cancer Immunology and Biotechnology
Program Overview
Gain a strong understanding of current and in-development immunotherapies for treating cancer and tumour immunology on our unique Cancer Immunology and Biotechnology MSc.
You'll learn everything from the basics of immunology and molecular biology of cancer before focusing on how to develop therapies like vaccines, monoclonal antibodies, CAR T cells and more. You'll also develop an understanding of the impact tumours have on the immune system and the immune system on tumours, as well as the business side of research.
Working with active cancer researchers and experts, you'll join the Centre for Cancer Sciences and conduct an in-depth six-month independent research project in the area of cancer immunology and biotechnology that interests you. The course will also see you make use of some of the latest technology in oncology and strengthen your ability to successfully evaluate and interpret cancer research data.
At Nottingham, you'll receive a thorough grounding in tumour immunology and the different immunotherapies that will help you succeed in your career tackling one of the world's biggest killers.
Application Fee
Application Fee: CAD 50 Tuition Fee
CAD 30,200 per year
*Note: The fee is approximate and is subject to change
Living Cost in University of Nottingham - University Park Campus
CAD 10,224 per year
*Note: The fee is approximate and is subject to change
The living costs include the total expenses per month, covering accommodation, public transportation, utilities (electricity, internet), books and groceries.
Funding
Check program website for more information about funding options.
